The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study
HANDE, Kenneth R, HAGEY, Anne, ROTHENBERG, Mace L, BERLIN, Jordan, YINGNA CAI, MEEK, Kysa, KOBAYASHI, Hiro, LOCKHART, A. Craig, MEDINA, Diane, SOSMAN, Jeffrey, GORDON, Gary B
Published in Clinical cancer research (01.05.2006)
Published in Clinical cancer research (01.05.2006)
Get full text
Journal Article
A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors
Fox, Elizabeth, Maris, John M, Widemann, Brigitte C, Goodspeed, Wendy, Goodwin, Anne, Kromplewski, Marie, Fouts, Molly E, Medina, Diane, Cohn, Susan L, Krivoshik, Andrew, Hagey, Anne E, Adamson, Peter C, Balis, Frank M
Published in Clinical cancer research (15.02.2008)
Published in Clinical cancer research (15.02.2008)
Get full text
Journal Article
A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors
Fox, Elizabeth, Maris, John M, Widemann, Brigitte C, Meek, Kysa, Goodwin, Anne, Goodspeed, Wendy, Kromplewski, Marie, Fouts, Molly E, Medina, Diane, Cho, Steve Y, Cohn, Susan L, Krivoshik, Andrew, Hagey, Anne E, Adamson, Peter C, Balis, Frank M
Published in Clinical cancer research (15.08.2006)
Published in Clinical cancer research (15.08.2006)
Get full text
Journal Article
Field assessment of active ingredient quantity in pharmaceutical tablets with limited calibration of near infrared spectra: An application to ciprofloxacin tablets
Awotunde, Olatunde, Cai, Jin, Azar, Christian Gabriel El, Medina, Diane, Eyolfson, Samantha I., Hayes, Kathleen, Waffo, Christelle, Djang’eing’a, Roland Marini, Ziemons, Eric M., Sacré, Pierre-Yves, Lieberman, Marya
Published in Journal of pharmaceutical and biomedical analysis (15.08.2024)
Published in Journal of pharmaceutical and biomedical analysis (15.08.2024)
Get full text
Journal Article
Web Resource
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
Mehta, Minesh P., Wang, Ding, Wang, Fen, Kleinberg, Lawrence, Brade, Anthony, Robins, H. Ian, Turaka, Aruna, Leahy, Terri, Medina, Diane, Xiong, Hao, Mostafa, Nael M., Dunbar, Martin, Zhu, Ming, Qian, Jane, Holen, Kyle, Giranda, Vincent, Curran, Walter J.
Published in Journal of neuro-oncology (01.04.2015)
Published in Journal of neuro-oncology (01.04.2015)
Get full text
Journal Article
Abstract CT149: Assessment of the cardiac safety of veliparib in a thorough QT/QTc study at therapeutic doses in patients with relapsed/refractory solid tumors: a randomized, placebo-controlled crossover study
Munasinghe, Wijith, Tolcher, Anthony, Calvo, Emiliano, Gordon, Michael, Jalving, Mathilde, de Vos-Geelen, Judith, Medina, Diane M., Bergau, Dennis M., Nuthalapati, Silpa, Hoffman, David M., Shepherd, Stacie L., Xiong, Hao
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors
Bell-McGuinn, Katherine M., Gray, Heidi J., Fleming, Gini F., Cristea, Mihaela C., Medina, Diane M., Xiong, Hao, Dudley, Matthew W., Dunbar, Martin, Giranda, Vincent L., Luo, Yan, McKee, Mark D., Martin, Lainie P.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751
Innocenti, Federico, Ramírez, Jacqueline, Obel, Jennifer, Xiong, Julia, Mirkov, Snezana, Chiu, Yi-Lin, Katz, David A, Carr, Robert A, Zhang, Wei, Das, Soma, Adjei, Araba, Moyer, Ann M, Chen, Pei Xian, Krivoshik, Andrew, Medina, Diane, Gordon, Gary B, Ratain, Mark J, Sahelijo, Leonardo, Weinshilboum, Richard M, Fleming, Gini F, Bhathena, Anahita
Published in Pharmacogenetics and genomics (01.07.2013)
Published in Pharmacogenetics and genomics (01.07.2013)
Get more information
Journal Article
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Fox, Elizabeth, Maris, John M, Cohn, Susan L, Goodspeed, Wendy, Goodwin, Anne, Kromplewski, Marie, Medina, Diane, Xiong, Hao, Krivoshik, Andrew, Widemann, Brigitte, Adamson, Peter C, Balis, Frank M
Published in Cancer chemotherapy and pharmacology (01.09.2010)
Published in Cancer chemotherapy and pharmacology (01.09.2010)
Get full text
Journal Article
A Phase I Study of ABT-751, an Orally BioavailableTubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors
FOX, Elizabeth, MARIS, John M, HAGEY, Anne E, ADAMSON, Peter C, BALIS, Frank M, WIDEMANN, Brigitte C, GOODSPEED, Wendy, GOODWIN, Anne, KROMPLEWSKI, Marie, FOUTS, Molly E, MEDINA, Diane, CONN, Susan L, KRIVOSHIK, Andrew
Published in Clinical cancer research (2008)
Get full text
Published in Clinical cancer research (2008)
Journal Article
A phase 1 study of ABT-751, an orally bioavailabletubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors
FOX, Elizabeth, MARIS, John M, COHN, Susan L, KRIVOSHIK, Andrew, HAGEY, Anne E, ADAMSON, Peter C, BALIS, Frank M, WIDEMANN, Brigitte C, MEEK, Kysa, GOODWIN, Anne, GOODSPEED, Wendy, KROMPLEWSKI, Marie, FOUTS, Molly E, MEDINA, Diane, CHO, Steve Y
Published in Clinical cancer research (2006)
Get full text
Published in Clinical cancer research (2006)
Journal Article